Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
- Market Wrap: Mobile Bolsters Facebook in Q2; FAA Halts Israel Flights for Second Day; Earnings Aplenty
- Facebook (FB) Tops Q2 EPS by 10c
- After-Hours Stock Movers 7/23: (FTNT) (ARIA) (FB) Higher; (ANGI) (TRIP) (CRUS) Lower (more...)
- Qualcomm, Inc. (QCOM) Tops Q3 EPS by 22c, Raises FY Guidance
- Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 63c; Boosts FY14 Revenue Outlook
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
You May Also Be Interested In
- Core Laboratories N.V. (CLB) Tops Q2 EPS by 1c, Offers Guidance
- Neustar (NSR) Tops Q2 EPS by 5c, Targets Top End of Rev. Guidance Range
- Stancorp Financial Group, Inc. (SFG) Misses Q2 EPS by 25c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!